Literature DB >> 7684835

The exon trapping assay partly discriminates against alternatively spliced exons.

A Andreadis1, P E Nisson, K S Kosik, P C Watkins.   

Abstract

A cosmid containing eight exons of the gene coding for the microtubule-associated tau protein was subjected to the exon trapping assay. All the constitutive exons contained in the cosmid (4, 5, 7 and 9) were efficiently captured regardless of size. Of the four alternatively spliced exons, three (3, 4A and 8) were not isolated by the assay, but the behavior of exon 6 depended on the identity of its flanking exons.

Mesh:

Substances:

Year:  1993        PMID: 7684835      PMCID: PMC309487          DOI: 10.1093/nar/21.9.2217

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  25 in total

1.  The organization of 3' splice-site sequences in mammalian introns.

Authors:  R Reed
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

2.  Exon definition may facilitate splice site selection in RNAs with multiple exons.

Authors:  B L Robberson; G J Cote; S M Berget
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

3.  Developmentally regulated expression of specific tau sequences.

Authors:  K S Kosik; L D Orecchio; S Bakalis; R L Neve
Journal:  Neuron       Date:  1989-04       Impact factor: 17.173

4.  Optimal conditions for supercoil DNA sequencing with the Escherichia coli DNA polymerase I large fragment.

Authors:  H M Lim; J J Pène
Journal:  Gene Anal Tech       Date:  1988 Mar-Apr

5.  Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family.

Authors:  A Himmler
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

6.  Selective inactivation of the exonuclease activity of bacteriophage T7 DNA polymerase by in vitro mutagenesis.

Authors:  S Tabor; C C Richardson
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

7.  Myosin light-chain 1/3 gene alternative splicing: cis regulation is based upon a hierarchical compatibility between splice sites.

Authors:  M E Gallego; B Nadal-Ginard
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

8.  Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains.

Authors:  A Himmler; D Drechsel; M W Kirschner; D W Martin
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

9.  Nucleotide substitutions within the cardiac troponin T alternative exon disrupt pre-mRNA alternative splicing.

Authors:  T A Cooper; C P Ordahl
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  5 in total

1.  Isolation of coding sequences from bovine cosmids by means of exon trapping.

Authors:  S Comincini; B Drisaldi; L Ferretti
Journal:  Mamm Genome       Date:  1997-07       Impact factor: 2.957

2.  Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons.

Authors:  A Andreadis; J A Broderick; K S Kosik
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

3.  Scanning for genes in large genomic regions: cosmid-based exon trapping of multiple exons in a single product.

Authors:  N A Datson; E van de Vosse; H G Dauwerse; M Bout; G J van Ommen; J T den Dunnen
Journal:  Nucleic Acids Res       Date:  1996-03-15       Impact factor: 16.971

4.  Use of an exon-trapping vector for the evaluation of splice-site mutations.

Authors:  Boris Schneider; Andrea Koppius; Reinhard Sedlmeier
Journal:  Mamm Genome       Date:  2007-08-09       Impact factor: 2.957

Review 5.  Regulation of human MAPT gene expression.

Authors:  Marie-Laure Caillet-Boudin; Luc Buée; Nicolas Sergeant; Bruno Lefebvre
Journal:  Mol Neurodegener       Date:  2015-07-14       Impact factor: 14.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.